Blueprint Medicines Corpo... (BPMC)

NASDAQ: BPMC · Real-Time Price · USD

99.11

9.61 (10.74%)

At close: May 01, 2025, 3:54 PM

Blueprint Medicines Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	508.82M	249.38M	204.04M	180.08M	793.74M	66.51M	44.52M	21.43M	27.77M
Cost of Revenue	20.16M	12.8M	17.81M	17.93M	425K	n/a	243.62M	144.69M	81.13M
Gross Profit	488.66M	236.58M	186.22M	162.15M	793.31M	66.51M	-199.1M	-123.26M	-53.36M
Operating Income	-212.04M	-486.28M	-549.25M	-648.46M	302.15M	-366.58M	-247.03M	-149.48M	-73.61M
Interest Income	40.66M	n/a	17.75M	2.39M	6.6M	13.73M	10.64M	3.42M	n/a
Pretax Income	-65.86M	-506.02M	-552.28M	-641.08M	314.94M	-347.69M	-236.64M	-148.12M	-72.5M
Net Income	-67.09M	-506.98M	-557.52M	-644.09M	313.88M	-328.7M	-236.64M	-148.12M	-72.5M
Selling & General & Admin	359.27M	295.14M	237.37M	195.29M	157.74M	96.39M	47.93M	27.99M	19.22M
Research & Development	341.43M	427.72M	477.42M	601.03M	326.86M	331.45M	243.62M	144.69M	81.13M
Other Expenses	n/a	n/a	8.95M	7.8M	-366K	-100K	10.46M	3.35M	551K
Operating Expenses	700.71M	722.86M	723.74M	804.13M	484.6M	427.84M	291.55M	172.67M	100.35M
Interest Expense	68.81M	n/a	16.77M	n/a	n/a	13.73M	73K	221K	469K
Selling & Marketing Expenses	96.6M	16.9M	18.1M	13.5M	9.4M	3.3M	n/a	n/a	n/a
Cost & Expenses	720.87M	735.66M	741.55M	822.06M	485.03M	427.84M	291.55M	172.67M	100.35M
Income Tax Expense	1.23M	968K	5.24M	3M	1.06M	-18.99M	10.46M	1.99M	-562K
Shares Outstanding (Basic)	62.86M	60.56M	59.64M	58.52M	54.53M	47.83M	43.87M	37.79M	27.49M
Shares Outstanding (Diluted)	62.86M	60.56M	59.64M	58.52M	56.17M	47.83M	43.87M	37.79M	27.49M
EPS (Basic)	-1.07	-8.37	-9.35	-11.01	5.76	-6.87	-5.39	-3.92	-2.64
EPS (Diluted)	-1.07	-8.37	-9.35	-11.01	5.59	-6.87	-5.39	-3.92	-2.64
EBITDA	19.23M	-470.36M	-515.41M	-628.3M	308.71M	-356.07M	-242.78M	-149.67M	-70.44M
EBIT	2.94M	-482.02M	-528.57M	-641.08M	314.94M	-361.33M	-247.03M	-151.25M	-72.03M
Depreciation & Amortization	16.29M	11.66M	20.1M	12.79M	12.35M	10.25M	4.25M	1.58M	1.58M